By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Genomic Health, Inc. 

301 Penobscot Drive

Redwood City  California  94063  U.S.A.
Phone: 650-556-9300 Fax: 650-556-1132


SEARCH JOBS

Genomic Health, Inc. (NASDAQ: GHDX) is the world's leading provider of genomic-based diagnostic tests that address both the overtreatment and optimal treatment of early-stage cancer, one of the greatest issues in healthcare today. The Oncotype DX® portfolio of breast, colon and prostate cancer tests applies advanced genomic science to reveal the unique biology of a tumor in order to optimize cancer treatment decisions. With half a million patients tested in more than 70 countries, the Oncotype DX tests have redefined personalized medicine by making genomics a critical part of cancer diagnosis and treatment. Based in Redwood City, Calif. with European headquarters in Geneva, Switzerland, the company is applying its world-class scientific and commercial expertise and infrastructure to lead the translation of genomic data into clinically-actionable results for treatment planning throughout the cancer patient's journey.


Key Statistics


Email:
Ownership: Public

Web Site: Genomic Health, Inc.
Employees:
Symbol: GHDX
 




Segment
Biotechnology





Company News
Genomic Health, Inc. (GHDX) Announces Favorable Draft Local Coverage Determination From Palmetto GBA On Medicare Coverage For The Oncotype DX Prostate Cancer Test 5/21/2015 6:49:48 AM
Genomic Health, Inc. (GHDX) Advances Liquid Biopsy Pipeline, Shows Ability To Accurately Monitor Urine For Presence Of Bladder Cancer 5/18/2015 6:53:56 AM
Genomic Health, Inc. (GHDX) Release: Oncotype DX Prostate Cancer Test Improves Risk Assessment For One In Four Men And Reduces Overall Healthcare Costs 5/15/2015 6:43:43 AM
Genomic Health, Inc. (GHDX) To Present Multiple Oncotype DX Studies And Positive Liquid Biopsy Results At American Urological Association Annual Meeting May 15-19 5/7/2015 12:20:37 PM
Genomic Health, Inc. (GHDX) To Present At The Bank of America (BAC) Merrill Lynch 2015 Healthcare Conference 5/6/2015 11:19:54 AM
Genomic Health, Inc. (GHDX) Announces First Quarter 2015 Financial Results And Reports Record Oncotype DX Test Volume 5/6/2015 7:57:48 AM
Genomic Health, Inc. (GHDX) Announces Publication of Oncotype DX Prostate Cancer Test Decision Impact Study In Urology Practice, Supporting Wider Adoption And Reimbursement 4/30/2015 6:23:03 AM
Genomic Health, Inc. (GHDX) To Announce First Quarter 2015 Financial Results And Host Conference Call On Tuesday, May 5, 2015 4/28/2015 10:56:53 AM
Genomic Health, Inc. (GHDX) Release: Multiple Data Presentations Demonstrate Positive Direct Patient Impact Of Oncotype DX Breast Cancer Test Globally 3/20/2015 7:06:52 AM
Genomic Health, Inc. (GHDX) Announces Year-End 2014 Financial Results, Provides 2015 Financial Outlook 2/11/2015 10:32:18 AM
12345678910...
//-->